224 related articles for article (PubMed ID: 35370935)
21. [Intrasellar gangliocytoma associated with growth hormone-producing pituitary adenoma. Case report].
Romero L; Arcos A; Bautista MD; Domínguez M; Medina JM; Arráez MA
Neurocirugia (Astur); 2012 Nov; 23(6):264-9. PubMed ID: 22963951
[TBL] [Abstract][Full Text] [Related]
22. [Combined neuronal and endocrine tumors of the sellar region].
Saeger W; Lüdecke DK; Losa M
Pathologe; 1997 Nov; 18(6):419-24. PubMed ID: 9451729
[TBL] [Abstract][Full Text] [Related]
23. Somatomammotrophic cells in GH-secreting and PRL-secreting human pituitary adenomas.
Bassetti M; Brina M; Spada A; Giannattasio G
J Endocrinol Invest; 1989 Nov; 12(10):705-12. PubMed ID: 2614009
[TBL] [Abstract][Full Text] [Related]
24. Ossifying pituitary adenoma co-existing with astrocytoma and pituitary adenoma associated with gangliocytoma: two unusual conditions.
Jaiswal S; Vij M; Jaiswal AK; Chand G; Behari S; Kumarjain V
Turk Neurosurg; 2012; 22(1):127-33. PubMed ID: 22274987
[TBL] [Abstract][Full Text] [Related]
25. Human growth hormone and prolactin secreting pituitary adenomas analyzed by in situ hybridization.
Lloyd RV; Cano M; Chandler WF; Barkan AL; Horvath E; Kovacs K
Am J Pathol; 1989 Mar; 134(3):605-13. PubMed ID: 2466405
[TBL] [Abstract][Full Text] [Related]
26. Mixed gangliocytoma-pituitary adenoma containing GH and GHRH co-secreting adenoma cells.
Teramoto S; Tange Y; Ishii H; Goto H; Ogino I; Arai H
Endocrinol Diabetes Metab Case Rep; 2019 Oct; 2019():. PubMed ID: 31581122
[TBL] [Abstract][Full Text] [Related]
27. An intrasellar pituitary adenoma-gangliocytoma presenting as acromegaly.
Lee MH; McKelvie P; Krishnamurthy B; Wang YY; Caputo C
Endocrinol Diabetes Metab Case Rep; 2017; 2017():. PubMed ID: 28469929
[TBL] [Abstract][Full Text] [Related]
28. Transdifferentiation of Neuroendocrine Cells: Gangliocytoma Associated With Two Pituitary Adenomas of Different Lineage in MEN1.
Sergeant C; Jublanc C; Leclercq D; Boch AL; Bielle F; Raverot G; Daly AF; Trouillas J; Villa C
Am J Surg Pathol; 2017 Jun; 41(6):849-853. PubMed ID: 28079577
[TBL] [Abstract][Full Text] [Related]
29. The clinical presentation of PIT1 positive pituitary neuroendocrine tumor immunonegative for growth hormone, prolactin, and thyroid stimulating hormone with analysis of clinical and immunostaining dissociation.
Hong S; Shinya Y; Trejo-Lopez JA; Gruber LM; Erickson D; Bendok BR; Chaichana KL; Atkinson JL; Marino MJ; Donaldson AM; Stokken JK; Westphal SA; Chang AY; Samson SL; Choby GW; Van Gompel JJ
Clin Neurol Neurosurg; 2024 Jan; 236():108075. PubMed ID: 38056042
[TBL] [Abstract][Full Text] [Related]
30. Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients.
Gsponer J; De Tribolet N; Déruaz JP; Janzer R; Uské A; Mirimanoff RO; Reymond MJ; Rey F; Temler E; Gaillard RC; Gomez F
Medicine (Baltimore); 1999 Jul; 78(4):236-69. PubMed ID: 10424206
[TBL] [Abstract][Full Text] [Related]
31. Structure-function correlations of growth hormone or/and prolactin-producing pituitary adenomas: an in vitro study with the reverse hemolytic plaque assay.
Thodou E; Kontogeorgos G; Kyrodimou E; Salla H; Ramyar L; Vamvassakis E; Piaditis G; Anagnostopoulos N; Tzanis S; Levedis A; Rologis D; Asa SL
J Endocrinol Invest; 1999 Oct; 22(9):671-80. PubMed ID: 10595830
[TBL] [Abstract][Full Text] [Related]
32. A case for hypothalamic acromegaly: a clinicopathological study of six patients with hypothalamic gangliocytomas producing growth hormone-releasing factor.
Asa SL; Scheithauer BW; Bilbao JM; Horvath E; Ryan N; Kovacs K; Randall RV; Laws ER; Singer W; Linfoot JA
J Clin Endocrinol Metab; 1984 May; 58(5):796-803. PubMed ID: 6423659
[TBL] [Abstract][Full Text] [Related]
33. Clinically silent somatotroph adenomas are common.
Wade AN; Baccon J; Grady MS; Judy KD; O'Rourke DM; Snyder PJ
Eur J Endocrinol; 2011 Jul; 165(1):39-44. PubMed ID: 21493729
[TBL] [Abstract][Full Text] [Related]
34. 'Silent' somatotropinoma.
Pawlikowski M; Kuta J; Fuss-Chmielewska J; Winczyk K
Endokrynol Pol; 2012; 63(2):88-91. PubMed ID: 22538745
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathological significance of baseline T2-weighted signal intensity in functional pituitary adenomas.
Dogansen SC; Yalin GY; Tanrikulu S; Tekin S; Nizam N; Bilgic B; Sencer S; Yarman S
Pituitary; 2018 Aug; 21(4):347-354. PubMed ID: 29460202
[TBL] [Abstract][Full Text] [Related]
36. Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomas.
Mete O; Gomez-Hernandez K; Kucharczyk W; Ridout R; Zadeh G; Gentili F; Ezzat S; Asa SL
Mod Pathol; 2016 Feb; 29(2):131-42. PubMed ID: 26743473
[TBL] [Abstract][Full Text] [Related]
37. A case of pituitary somatotroph adenoma with concomitant secretion of growth hormone, prolactin, and adrenocorticotropic hormone--an adenoma derived from primordial stem cell, studied by immunohistochemistry, in situ hybridization, and cell culture.
Matsuno A; Sasaki T; Mochizuki T; Fujimaki T; Sanno N; Osamura Y; Teramoto A; Kirino T
Acta Neurochir (Wien); 1996; 138(8):1002-7. PubMed ID: 8890999
[TBL] [Abstract][Full Text] [Related]
38. Metabolic glucose status and pituitary pathology portend therapeutic outcomes in acromegaly.
Cheng S; Al-Agha R; Araujo PB; Serri O; L Asa S; Ezzat S
PLoS One; 2013; 8(9):e73543. PubMed ID: 24039977
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical detection of glycoprotein hormone alpha subunit in somatoprolactinic and pure somatotroph adenomas.
Vantyghem MC; Cortet C; Bauters C; Gevaert MH; Dewailly D; Lefebvre J; Mazzucca M
J Endocrinol Invest; 1998; 21(7):434-40. PubMed ID: 9766257
[TBL] [Abstract][Full Text] [Related]
40. Double pituitary adenomas: six surgical cases.
Sano T; Horiguchi H; Xu B; Li C; Hino A; Sakaki M; Kannuki S; Yamada S
Pituitary; 1999 May; 1(3-4):243-50. PubMed ID: 11081204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
